Z-0494-2025 Class II Ongoing
FDA device recall Z-0494-2025 was initiated by Abbott Medical on Oct 17, 2024 and is designated Class II. Reason for recall: A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the… The recall status is ongoing. Affected quantity: 8 OUS.
Recall details
- Product Type
- Devices
- Report Date
- Nov 27, 2024
- Initiation Date
- Oct 17, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8 OUS
Product description
Abbott Navitor, Vision Technology, Transcatheter Aortic Heart Valve, 27 mm, NVRO-27, Sterile
Reason for recall
A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.
Distribution pattern
New York, Australia, Belgium, Germany, Iran, Israel, Japan, Kazakhstan, Oman, Poland, Romania, Slovakia, Spain, Turkey, United Kingdom.
Code information
UDI-DI (GTIN): 5415067045799, Serial Numbers: 20158135, 20172203, 20183968, 20184552, 20184670, 20184675, 20190249, & 20213055.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0494-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026